Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim M Mulleners

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cephalalgia : an International Journal of Headache|September 24, 2025
Greater occipital nerve injection with methylprednisolone as transitional therapy in episodic cluster headache: Results from an RCTRoemer B Brandt, Wim M Mulleners, Emile Couturier, et al.
Headache|November 13, 2025
Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient-reported outcome measureWillemijn C Naber, Paulien J van Tilborg, Roemer B Brandt, et al.
Environment International|May 20, 2019
Parkinson's disease and long-term exposure to outdoor air pollution: A matched case-control study in the NetherlandsRosario Toro, George S Downward, Marianne van der Mark, et al.
Environment International|July 14, 2017
Environmental exposure to pesticides and the risk of Parkinson's disease in the NetherlandsMaartje Brouwer, Anke Huss, Marianne van der Mark, et al.
The Lancet. Neurology|September 19, 2020
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trialWim M Mulleners, Byung-Kun Kim, Miguel J A Láinez, et al.
The Lancet. Neurology|June 19, 2021
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trialLeopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cephalalgia : an International Journal of Headache|September 24, 2025
Greater occipital nerve injection with methylprednisolone as transitional therapy in episodic cluster headache: Results from an RCTRoemer B Brandt, Wim M Mulleners, Emile Couturier, et al.
Headache|November 13, 2025
Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient-reported outcome measureWillemijn C Naber, Paulien J van Tilborg, Roemer B Brandt, et al.
Environment International|May 20, 2019
Parkinson's disease and long-term exposure to outdoor air pollution: A matched case-control study in the NetherlandsRosario Toro, George S Downward, Marianne van der Mark, et al.
Environment International|July 14, 2017
Environmental exposure to pesticides and the risk of Parkinson's disease in the NetherlandsMaartje Brouwer, Anke Huss, Marianne van der Mark, et al.
The Lancet. Neurology|September 19, 2020
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trialWim M Mulleners, Byung-Kun Kim, Miguel J A Láinez, et al.
The Lancet. Neurology|June 19, 2021
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trialLeopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg, et al.
Pageof 3